Aberrant Promoter Methylation in Human DAB2 Interactive Protein ( hDAB2IP ) Gene in Breast Cancer
- 15 March 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (6) , 2082-2089
Abstract
Purpose: Human DOC-2/DAB2 interactive protein (hDAB2IP) gene is a novel member of the Ras GTPase-activating family and has been demonstrated to be a tumor suppressor gene inactivated by methylation in prostate cancer. We analyzed methylation and expression status of hDAB2IP in breast cancer. Experimental Design: The promoter region of hDAB2IP was divided into two regions (m2a and m2b) following our previous report on prostate cancer, and methylation status was determined in breast cancer cell lines with bisulfited DNA sequencing. Expression was semiquantified with real-time reverse transcription-PCR to find that aberrant methylation showed the inverse relationship with expression. On the basis of sequence data, we developed methylation-specific PCR for m2a and m2b regions and applied to samples. Results: Aberrant methylation was detected in 11 of 25 breast cancer cell lines (44%) and 15 of 39 primary tumors (38%) at the m2a region and in 12 of 25 cell lines (48%) and 13 of 39 tumors (33%) at the m2b region. In addition, gene expression was restored in methylated cell lines with 5-aza-2′-deoxycytidine, confirming that methylation caused gene down-regulation. We also examined the relationship between hDAB2IP methylation and clinicopathologic features in primary tumors and found that methylation in the m2b region was associated with progressive nodal status of tumors. Conclusions: We developed methylation-specific PCR for hDAB2IP and examined its methylation status in breast cancer. Our results demonstrate that hDAB2IP methylation frequently is present in breast cancer and plays a key role in hDAB2IP inactivation, suggesting the relationship between hDAB2IP methylation and lymph node metastasis of breast cancer.Keywords
This publication has 17 references indexed in Scilit:
- P-308 Epigenetic down regulation of death associated protein kinase in lung cancersLung Cancer, 2003
- Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell LinesJournal of Biological Chemistry, 2003
- The Mechanism of Growth-inhibitory Effect of DOC-2/DAB2 in Prostate CancerJournal of Biological Chemistry, 2002
- The Inhibitory Role of DOC-2/DAB2 in Growth Factor Receptor-mediated Signal CascadeJournal of Biological Chemistry, 2001
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI: Journal of the National Cancer Institute, 2000
- Regulation of Rat DOC-2 Gene during Castration-Induced Rat Ventral Prostate Degeneration and Its Growth Inhibitory Function in Human Prostatic Carcinoma CellsEndocrinology, 1998
- DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseasesOncogene, 1998
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- [15] Isolation of genomic DNA1987
- Altering gene expression with 5-azacytidineCell, 1985